Skip to content
drillr.ai

SIBN

SI-BONE, Inc.

NASDAQ · USHealthcareMedical - Devices
$17.12-1.50%

Price as of Jul 20, 2026

SIBN news

SI-BONE, Inc. news

A server-rendered, paginated timeline of the latest available company news.

  1. SI-BONE To Report Second Quarter 2026 Financial Results on August 3, 2026

    SANTA CLARA, Calif., July 20, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today announced it will report financial results for the second quarter of 2026 after market close on Monday, August 3, 2026. Management will host a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time Investors interested in listening to the conference call may do so by

    Globe Newswire ·

  2. ViCentra Appoints Ian Wells as Chief Financial Officer and Adds Medtech Veteran Tom West to its Board

    * Ian Wells, former Global Chief Financial Officer of HOYA Vision Care, appointed CFO, bringing multi-billion-dollar P&L leadership and capital-markets discipline * Tom West, who led Intersect ENT to its $1.1 billion acquisition by Medtronic and Nalu Medical to its $600 million acquisition by Boston Scientific, joins as an Independent Board Member * Appointments build the financial and governance foundation for ViCentra’s next phase, following the recent scale-up of commercial manufacturing UTRE

    Globe Newswire ·

  3. SI-BONE To Present at Truist Securities 2026 MedTech Conference on June 16, 2026

    SANTA CLARA, Calif., June 04, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today announced that the company will be participating in the upcoming 2026 Truist Securities MedTech Conference in Boston, MA. Management will be hosting a fireside chat on Tuesday, June 16, 2026, at 5:40 a.m. Pacific Time/ 8:40 a.m. Eastern Time. Investors interested in listening to the confer

    Globe Newswire ·

  4. SI-BONE, Inc. Reports Financial Results for the First Quarter 2026 and Raises 2026 Guidance

    First Quarter 2026 Financial Highlights (all comparisons are to the prior year period) * Worldwide revenue of $52.6 million, representing growth of 11.2% * U.S. revenue of $49.3 million, representing growth of 10.0% * Gross margin of 79.8%    * Net loss of $4.3 million, representing an improvement of 33.8%   * Adjusted EBITDA of $2.5 million, representing an improvement of over 440% * $144.7 million in cash and equivalents Recent Operational Highlights (any comparisons are to the prior year peri

    Globe Newswire ·

  5. SI-BONE To Present at BofA Securities 2026 Healthcare Conference on May 12, 2026

    SANTA CLARA, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today announced that the company will be participating in the upcoming 2026 BofA Securities Healthcare Conference in Las Vegas, NV. Management will be hosting a fireside chat on Tuesday, May 12, 2026, at 8:00 a.m. Pacific Time/11:00 a.m. Eastern Time. Investors interested in listening to the co

    Globe Newswire ·

  6. SI-BONE To Report First-Quarter 2026 Financial Results on May 11, 2026

    SANTA CLARA, Calif., April 20, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today announced it will report financial results for the first quarter of 2026 after market close on Monday, May 11, 2026. Management will host a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time Investors interested in listening to the conference call may do so by re

    Globe Newswire ·